Pages that link to "Q30493152"

The following pages link to In vitro and in vivo demonstration of risperidone implants in mice. (Q30493152):

Displaying 22 items.

• The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal. (Q34418847) (← links)
• A rapid method for creating drug implants: translating laboratory-based methods into a scalable manufacturing process (Q34629537) (← links)
• A nanoparticle depot formulation of 4-(N)-stearoyl gemcitabine shows a strong anti-tumour activity (Q36515306) (← links)
• Antipsychotic Dosing and Drug Delivery (Q37839932) (← links)
• PLGA: a unique polymer for drug delivery (Q38309875) (← links)
• Improving drug delivery technology for treating neurodegenerative diseases (Q38769989) (← links)
• Implantable and transdermal polymeric drug delivery technologies for the treatment of central nervous system disorders (Q38857113) (← links)
• Drug-eluting nasal implants: formulation, characterization, clinical applications and challenges. (Q39185164) (← links)
• Development of novel risperidone implants using blends of polycaprolactones and in vitro in vivo correlation studies. (Q40952775) (← links)
• Long-acting injectable antipsychotics in first-episode schizophrenia (Q41991738) (← links)
• Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier (Q42153590) (← links)
• In vitro-in vivo correlations of scalable PLGA-risperidone implants for the treatment of schizophrenia (Q43084552) (← links)
• Development of a novel 3-month drug releasing risperidone microspheres. (Q43153854) (← links)
• Ketamine modulates theta and gamma oscillations. (Q45937104) (← links)
• Studies on biodegradable polymeric nanoparticles of risperidone: in vitro and in vivo evaluation (Q46569308) (← links)
• Lessons learned in the development of sustained release penicillin drug delivery systems for the prophylactic treatment of rheumatic heart disease (RHD). (Q48100625) (← links)
• A method to slow down the ionization-dependent release of risperidone loaded in a thermoresponsive poly(N-acryloyl glycinamide) hydrogel (Q50180541) (← links)
• Poly(lactic-co-glycolic acid) devices: Production and applications for sustained protein delivery. (Q54256288) (← links)
• Injectable Polymers (Q57341085) (← links)
• Implantable Polymeric Drug Delivery Devices: Classification, Manufacture, Materials, and Clinical Applications. (Q64915620) (← links)
• Chemopreventive efficacy of curcumin-loaded PLGA microparticles in a transgenic mouse model of HER-2-positive breast cancer (Q87851859) (← links)
• Development of a Biodegradable Subcutaneous Implant for Prolonged Drug Delivery Using 3D Printing (Q89510821) (← links)